In the published article, the author list was missing the signs and an indication. The correct authors list is “Huan Shi1,2,†, Xin-Yu Li1,†, Yao Chen1,†, Xing Zhang3,†, Yong Wu4, Zi-Xuan Wang4, Pan-Hong Chen1, Hui-Qi Dai4, Ji Feng4, Sayantan Chatterjee1, Zhong-Jie Li1, Xiao-Wei Huang4, Hong-Qiao Wei1, Jigang Wang3, Guo-Dong Lu4,5,6* and Jing Zhou1*” and it should also include one statement “†These authors contributed equally to this work” as an indication for “†” in the author list in the published article.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Summary
Keywords
quercetin, vascular endothelial growth factor/PI3K/Akt, mitochondria, apoptosis, acute myeloid leukemia
Citation
Shi H, LI X-Y, Chen Y, Zhang X, Wu Y, Wang Z-X, Chen P-H, Dai H-Q, Feng J, Chatterjee S, Li Z-J, Huang X-W, Wei H-Q, Wang J, Lu G-D and Zhou J (2021) Corrigendum: Quercetin Induces Apoptosis Via Downregulation of VEGF/Akt Signaling Pathway in Acute Myeloid Leukemia Cells. Front. Pharmacol. 11:640750. doi: 10.3389/fphar.2020.640750
Received
12 December 2020
Accepted
14 December 2020
Published
08 February 2021
Approved by
Frontiers in Pharmacology Editorial Office, Frontiers Media SA, Switzerland
Volume
11 - 2020
Updates
Copyright
© 2021 Shi, Li, Chen, Zhang, Wu, Wang, Chen, Dai, Feng, Chatterjee, Li, Huang, Wei, Wang, Lu and Zhou.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jing Zhou, gardenia_zhou@hotmail.com; orcid.org/0000-0002-2475-7783Guo-Dong Lu, golden_lu@hotmail.comorcid.org/0000-0001-6056-3196
† These authors have contributed equally to this work
This article was submitted to Pharmacology of Anti-Cancer Drugs, a section of the journal Frontiers in Pharmacology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.